Suchergebnisse - "Rejeski, Kai"

PubPharm (64)

1

Applying the EHA/EBMT grading for ICAHT after CAR-T : comparative incidence and association with infections and mortality

enthalten in: Blood advances | 2024

von Rejeski, K. | Wang, Y. | Hansen, D. | +14

2

T-Cell Malignant Neoplasms After Chimeric Antigen Receptor T-Cell Therapy

enthalten in: JAMA oncology | 2024

von Storgard, R. | Rejeski, K. | Perales, M. | +2

3

Comparative performance of scFv-based anti-BCMA CAR formats for improved T cell therapy in multiple myeloma

enthalten in: Cancer immunology, immunotherapy : CII | 2024

von Stock, S. | Fertig, L. | Gottschlich, A. | +12

4

Comparative performance of scFv-based anti-BCMA CAR formats for improved T cell therapy in multiple myeloma

enthalten in: Cancer immunology immunotherapy | 2024

von Stock, S. | Fertig, L. | Gottschlich, A. | +12

5

Development and validation of an automated computational approach to grade immune effector cell-associated hematotoxicity

enthalten in: Bone marrow transplantation | 2024

von Liang, E. | Rejeski, K. | Fei, T. | +8

6

Navigating the prognostic role of transfusions after CAR-T

enthalten in: Blood advances | 2024

von Alhomoud, M. | Rejeski, K.

CommentOn: Blood Adv. 2024 Mar 26;8(6):1573-1585. - PMID 38181767

7

Baseline Serum Inflammatory Proteins Predict Poor CAR T Outcomes in Diffuse Large B-cell Lymphoma

enthalten in: Blood cancer discovery | 2024

von Faramand, R. | Lee, S. | Jain, M. | +30

8

Non-relapse mortality after CAR T-cell therapy: A systematic review and meta-analysis of 7,788 lymphoma and myeloma patients

enthalten in: ResearchSquare.com | 2024

von Rejeski, K. | Santos, D. | Tix, T. | +7

9

Predictive value of pre-infusion tumor growth rate for the occurrence and severity of CRS and ICANS in lymphoma under CAR T-cell therapy

enthalten in: Annals of hematology | 2024

von Winkelmann, M. | Blumenberg, V. | Rejeski, K. | +11

10

Recent Bendamustine Treatment Before Apheresis Has a Negative Impact on Outcomes in Patients With Large B-Cell Lymphoma Receiving Chimeric Antigen Receptor T-Cell Therapy

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Iacoboni, G. | Navarro, V. | Martín-López, A. | +21

1
2
3
4
5
6
7
Nächster »
[7]